Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Breast Disease(Electronic Edition) ›› 2007, Vol. 01 ›› Issue (03): 36-39. doi: 10.3877/cma.j.issn.1674-0807.2007.03.011

• Clinical Research • Previous Articles     Next Articles

Comparative study of preoperative and postoperative occult tumor cells in peripheral blood of breast cancer patients undergoing E-ALND and ALND

Mei-qin GUO1, Jun JIANG,1(), Lin-jun FAN1, Xin-hua YANG1   

  1. 1.Breast Disease Center,Southwest Hospital,Third Military Medical University,Chongqing 400038,China
  • Received:2007-04-18 Online:2007-06-01 Published:2024-12-12
  • Contact: Jun JIANG

Abstract:

Objective

To evaluate the safety of endoscopic axillay lymph node dissection(E-ALND)by liposuction.

Methods

Sixty-four cases of breast cancer were divided into an E-ALND group and a traditional ALND group,32 cases in each group.CK-19 mRNA copy numbers in peripheral blood were detected with SYBR Green I real time polymerase chain reaction before and after operation.

Results

The positive expression rate of CK-19 mRNA was 32.81%in peripheral blood in the 64 patients,and 31.25%and 34.38%in the E-ALND group and the ALND group,respectively.The likelihood of hemotogenous dissemination of tumor cells was 4.34%and 8.70%in the E-ALND group and the ALND group,respectively;OTC(occult tumor cell)in peripheral blood of patients who underwent preoperative chemotherapy could still be detected,and increased with the upgrading of breast cancer stage.

Conclusions

There is no difference in hemotogenous dissemination of tumor cells in breast cancer between E-ALND and traditional ALND.Compared with the ALND group,the likelihood of hemotogenous dissemination of tumor cells does not increase in the E-ALND group.

Key words: Endoscopy, Breast neoplasms, Axillary lymph node dissection, Occult tumor cell

京ICP 备07035254号-13
Copyright © Chinese Journal of Breast Disease(Electronic Edition), All Rights Reserved.
Tel: 0086-10-51322630 E-mail: jcbd@medmail.com.cn
Powered by Beijing Magtech Co. Ltd